Pharmaceuticals & Biotechnology (4570)

21,087.13
   
  • 52 Week High: 24,649.93
  • 52 Week Low: 18,687.04

Latest ShareCast News

Hutchmed China upbeat on results from lung cancer trial

By Josh White

Date: Monday 02 Jun 2025

(Sharecast News) - Hutchmed China reported positive interim results from its phase three 'SACHI' trial on Monday, showing that the combination of savolitinib and osimertinib significantly improved progression-free survival (PFS) in patients with advanced EGFR mutation-positive non-small cell lung cancer (NSCLC) and MET amplification, following progression on first-line EGFR inhibitor therapy.

Pharmaceuticals & Biotechnology ShareCast News

Indivior to cancel secondary listing in London 02-Jun-2025 ShareCast
GSK's linerixibat to be reviewed by US FDA 02-Jun-2025 ShareCast
Aptamer signs second Optimer programme contract ... 30-May-2025 ShareCast
Hvivo client cancels 'significant' HCT trial con... 30-May-2025 ShareCast
Sareum starts toxicology studies for lead inhibi... 29-May-2025 ShareCast

Pharmaceuticals & Biotechnology Regulatory News

Final results for year to 31 March 2025 03-Jun-2025 07:00 RNS
Second Patient Passes Initial Safety Tests 03-Jun-2025 07:00 RNS
New Evaluation and Material Transfer Agreement 03-Jun-2025 07:00 RNS
Transaction in Own Shares 03-Jun-2025 07:00 RNS
Issue of Equity and Total Voting Rights 03-Jun-2025 07:00 RNS

Pharmaceuticals & Biotechnology Newspaper Links

Small companies roundup: Sinclair IS Pharma cons... 27-Nov-2014 Express & Star
MARKET REPORT: Buyers lining up for Sinclair sal... 26-Nov-2014 Daily Mail
Reneuron tests stem cell stroke treatment 03-Sep-2014 The Herald
AstraZeneca buys the rights to an asthma treatme... 13-Jun-2014 Daily Mail
AstraZeneca in new £138million asthma drug deal 13-Jun-2014 Express & Star

Pharmaceuticals & Biotechnology Tips & Analysis

Questor :GW Pharmaceuticals 04-Dec-2014 Telegraph
Questor : Hikma Pharmaceuticals 13-Mar-2014 Telegraph
Investment Column:BTG 06-Oct-2011 The Independent
Investment Column:Genus 09-Sep-2011 The Independent
Questor :Dechra Pharmaceuticals 08-Sep-2011 Telegraph

Pharmaceuticals & Biotechnology News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 21,087.13
Closing Price Change -141.42
% Change -0.67 %
02-Jun-25 Close 21,087.13

Top Risers

Price Change
VRCI 1.38p +10.0%
ANCR 300.00p +7.1%
ANIC 6.52p +5.2%
HELD 0.99p +4.2%
PRTC 138.00p +1.3%
FUM 9.25p +1.2%
OXB 328.50p +1.1%
SBTX 18.88p +0.7%
GSK 1,517.00p +0.7%
HIK 2,148.00p +0.4%

Top Fallers

Price Change
CIZ 1.85p -21.3%
OPTI 12.80p -11.7%
APTA 0.35p -8.0%
AGY 6.80p -4.2%
FARN 252.50p -3.8%
INDV 916.00p -3.0%
HCM 201.00p -2.9%
AVCT 37.00p -2.6%
EDEN 3.85p -2.5%
IXI 11.00p -2.2%

Top of Page